On-Demand Cell Line Development Webinars

  1. Accelerating Antibody Development: A Proven Path From Gene To GMP 6/5/2026

    Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.

  2. From Gene Editing To NGS-Based T Cell Characterization 6/4/2026

    Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

  3. Faster Clones, Simpler Process: What's Changing In CHO Expression? 6/3/2026

    This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

  4. Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing 6/2/2026

    See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

  5. Advancing Therapeutic Discovery With High-Throughput Electroporation 5/21/2026

    Learn how high-throughput electroporation streamlines genetic material delivery for cell therapy and drug discovery, offering speed, precision, and scalability across hard-to-transfect cell types.

  6. From DNA To IND In As Little As 6 Months 4/27/2026

    Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.

  7. Unlock The Potential Of GPEx Lightning Accelerate Your HEK Cell Line Development 3/25/2026

    Discover how an advanced cell line development platform now supports HEK cells alongside CHO, enabling rapid, scalable production of complex biologics while saving up to 12 weeks on development timelines.

  8. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

    Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

  9. Achieving Rapid, High-Titer Expression For Next-Generation Biologics 3/24/2026

    Uncover how tunable expression technology achieves optimal chain pairing and high titers for complex biologics, from four-chain bispecifics to difficult-to-express proteins, using platform processes.

  10. Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development 3/19/2026

    Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.